Cardiac Science reports record profits

Cardiac Science Corporation, a manufacturer of cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced revenue for the quarter ended Sept. 30 of $54 million, an increase of 20 percent over the prior year period. The company reported net income of $2.5 million, or $0.11 per diluted share in the third quarter, compared to net income of $1.8 million, or $0.08 per diluted share in the third quarter of 2007, an increase of 41 percent. The company generated $6.4 million in cash from operating activities during the quarter, and had $33.4 million in cash and short-term investments as of Sept. 30.